Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Akebia Therapeutics, Inc. (AKBA)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -92.6-282.8-383.5-279.7-143.6-73.7-135.7-60.7
Depreciation and amortization   [+]37.738.033.638.62.40.60.30.1
Asset impairment charges  30.215.6135.67.1    
Stock-based compensation  17.822.724.511.919.08.95.84.7
Change in working capital   [+]-5.2-119.318.1-69.0102.122.7-10.63.9
Other operating activities  -61.272.861.433.5-77.4-14.6198.1-0.4
Cash from operations  -73.2-253.0-110.4-257.4-97.5-56.257.9-52.4
   
Capital expenditures  -0.1-0.1-0.3-6.7-1.6-1.6-2.7-0.4
Sales of short-term investments, net   [+] 40.0-39.7217.832.1-175.615.4-13.3
Other cash from investing      6.1   
Cash from investing  -0.139.9-40.0211.236.6-177.312.7-13.7
   
Issuance of common stock, net  7.188.2209.425.495.5114.666.782.8
Option exercises  0.50.71.20.60.61.30.10.4
Other cash from financing  8.046.323.564.21.83.00.30.7
Cash from financing  14.6133.7231.789.096.6116.266.983.1
   
Free cash flow  -73.3-253.0-110.7-264.1-99.1-57.855.2-52.8
        Per share (diluted)  ($0.40)($1.52)($0.80)($2.23)($1.71)($1.33)$1.46($2.00)
   
Cash paid for interest  6.89.67.80.8    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy